Market Tracker

05/26 10:02pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
40.51 -0.37 / -0.91%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.51 0.00 / 0.00%
 
Volume: 1.3K

Today’s Trading

Previous close40.88
Today’s open40.77
Day’s range39.72 - 41.35
Volume440,316
Average volume (3 months)438,818
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio198.4
Price/Sales10.13
Price/Book11.99

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.40-1.25%
MACKMerrimack Pharmaceut...-0.31-2.47%
INSMInsmed Inc-0.49-2.17%
ZSPHZS Pharma Inc+0.96+1.66%
Data as of 3:59pm ET, 05/26/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts